compared

Current COVID Symptoms: Common Symptoms Now Compared to Earlier in Pandemic

Current COVID Symptoms: Common Symptoms Now Compared to Earlier in Pandemic

As omicron subvariants continue to make up roughly all COVID cases in the U.S., and as new variants continue to emerge, are symptoms shifting? According to the latest update from the CDC, the BA.5 lineage of the omicron variant is now the most prevalent strain of the virus in the U.S., accounting for more than …

Current COVID Symptoms: Common Symptoms Now Compared to Earlier in Pandemic Read More »

BA.5 omicron variant may lead to higher risk for reinfection and severe outcomes, compared to other variants

NEWYou can now listen to Fox News articles! The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Reinfections, severe outcomes may be more common with BA.5. Compared with the earlier Omicron BA.2 …

BA.5 omicron variant may lead to higher risk for reinfection and severe outcomes, compared to other variants Read More »

Psilocybin microdosers display mental health improvement during 1 month period compared to non-microdosers

Psilocybin microdosers display mental health improvement during 1 month period compared to non-microdosers

Psilocybin, the active compound in “magic mushrooms,” has been shown to be a promising treatment for various mental health issues. New research published in Scientific Reports found that people who microdose psychedelics displayed greater improvements in mental health and mood over the span of 1 month compared to non-microdosers. Most of the research on psilocybin …

Psilocybin microdosers display mental health improvement during 1 month period compared to non-microdosers Read More »

Psilocybin microdosers display mental health improvement during 1 month period compared to non-microdosers

Psilocybin microdosers display mental health improvement during 1 month period compared to non-microdosers

Psilocybin, the active compound in “magic mushrooms,” has been shown to be a promising treatment for various mental health issues. New research published in Scientific Reports found that people who microdose psychedelics displayed greater improvements in mental health and mood over the span of 1 month compared to non-microdosers. Most of the research on psilocybin …

Psilocybin microdosers display mental health improvement during 1 month period compared to non-microdosers Read More »